Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
09/2003
09/18/2003US20030176477 Isothiazolecarboxylic acid derivatives and their use as microbicides
09/18/2003US20030176476 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
09/18/2003US20030176475 For therapy of disorders of the gastrointestinal system, and of the central nervous system
09/18/2003US20030176473 For use in cancer therapy
09/18/2003US20030176463 For therapy of disease states resulting from angiogenesis; can be administered orally
09/18/2003US20030176460 Piperidine compounds for use as ccr-3 inhibitors
09/18/2003US20030176454 N-coating heterocyclic compounds
09/18/2003US20030176451 Reacting a heterocyclic-methanesulfonyl substituted-quinazolineamine compound with amine compound
09/18/2003US20030176447 For therapy of cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease
09/18/2003US20030176445 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists
09/18/2003US20030176433 For therapy and prophylaxis of hepatitis C virus (HCV) infection
09/18/2003US20030176432 Cyclic and heterocyclic N-substituted alpha-iminohydroxamic and -carboxylic acids
09/18/2003US20030176425 Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators
09/18/2003US20030176419 As inhibitors of the retinoic acid-metabolism, as drugs
09/18/2003US20030176418 For therapy of Alzheimer's disease, Parkinson's disease, schizophrenia, Huntington's chorea, Friederich's ataxia, Gilles de la Tourette's Syndrome, Down Syndrome, Pick disease, dementia, clinical depression, age- related cognitive decline
09/18/2003US20030176417 Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium compounds
09/18/2003US20030176412 2-substituted thiazolidinones as beta-3 adrenergic receptor agonists
09/18/2003US20030176400 For therapy of allergic diseases such as allergic rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial asthma, food allergy, etc., systemic mastocytosis
09/18/2003US20030176368 For therapy of cancer
09/18/2003US20030176361 Having cytoprotective activity and protective activity for neuroinflammation, and neurodegenerative disorders; for use in therapy of stroke, cerebral ischemia, myocardial infarction, myocardial ischemia, chronic heart failure, inflammation
09/18/2003CA2478765A1 Bicyclic heterocycles for the treatment of diabetes and other diseases
09/18/2003CA2478701A1 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino) pyrimidine with cdk inhibitory activity
09/18/2003CA2478342A1 Heterocyclic amide derivatives for the treatment of diabetes and other diseases
09/17/2003EP1343817A2 Novel treatment
09/17/2003EP1343780A1 Piperazine derivatives for treatment of bacterial infections
09/17/2003EP1343778A2 Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists
09/17/2003EP1343775A2 Piperazine derivatives
09/17/2003EP1343774A1 1,1-dioxo-2h-1, 2-benzothiazine-3-carboxamide derivatives, method for preparing same and pharmaceutical compositions comprising same
09/17/2003EP1343771A1 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors
09/17/2003EP1343761A1 Piperidine mch antagonists and their use in the treatment of obesity
09/17/2003EP1343756A2 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
09/17/2003EP1343561A1 Serine protease inhibitors
09/17/2003EP1343505A1 Cxcr3 antagonists
09/17/2003EP1343503A1 Heteroaryl urea neuropeptide y y5 receptor antagonists
09/17/2003EP1343499A2 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
09/17/2003EP1314426A9 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
09/17/2003EP1224174B1 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
09/17/2003EP1196411B1 Bradykinin b1 receptor antagonists
09/17/2003EP1194428B1 Heteroaryl protease inhibitors and diagnostic imaging agents
09/17/2003EP1177194B1 4-(3',4'-heterocyclyl benzoyl) pyrazoles as herbicidal agents
09/17/2003EP1042327B1 A process for the reduction of oxiranyl epothilones to olefinic epothilones
09/17/2003EP0910566B1 Heterocyclic compounds and their preparation and use
09/17/2003EP0889034B1 Aminopyridine derivatives
09/17/2003CN1443186A Thiazolidinedione salt for treatment of diabetes mellitus
09/17/2003CN1443185A 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2, 4-dione hydriodide as pharmaceutical
09/17/2003CN1443180A Novel compounds having antiinflamatory activity process for their preparation and pharmaceutical compositions containing them
09/17/2003CN1443177A Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators
09/17/2003CN1443173A Substituted imidazoles as TAFI a inhibitors
09/17/2003CN1443170A Capsaicin receptor ligands
09/17/2003CN1443167A Azacyclic compounds for use in treatment of 5-serotonin related diseases
09/17/2003CN1443164A Pyrrolidine derivatives as metalloprotease inhibitors
09/17/2003CN1442416A Helerocyclic substituted benzoxazine cyclic compound having biological activity
09/17/2003CN1121404C Antifungal agent and its preparing process and intermediate
09/17/2003CN1121399C Isothiazolcarboxylic acid derivatives
09/17/2003CN1121398C Alicyclic acylated heterocyclic derivatives
09/17/2003CN1121392C Substituted pyrimidine (thi) ones
09/16/2003US6620941 Process for the preparation of thiazolidinedione derivatives
09/16/2003US6620840 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
09/16/2003US6620839 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
09/16/2003US6620831 Indazoles substituted with 1,1-dioxoisothiazolidine useful as inhibitors of cell proliferation
09/16/2003US6620828 Antiproliferative agents
09/16/2003US6620827 PPARγ modulators
09/16/2003US6620811 Isonicotin- and nicotinamide derivatives of benzothiazoles
09/16/2003CA2249009C Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
09/16/2003CA2085802C 5,6-disubstituted-3-pyridylmethyl ammonium halide compounds useful for the preparation of 5-(substituted methyl) -2,3-pyridinedicarboxylic acids
09/16/2003CA2046429C Imide derivatives, and their production and use
09/12/2003WO2003074521A1 Derivatives of epothilone b and d and synthesis thereof
09/12/2003WO2003074520A1 Thiadiazolylpiperazine derivatives useful for treating or preventing pain
09/12/2003WO2003074519A1 Coumarines useful as biomarkers
09/12/2003WO2003074518A1 Thiazole derivatives and their use d2- and 5-ht1a-receptor ligands
09/12/2003WO2003074513A2 Indole amide derivatives and their use as glycogen phosphorylase inhibitors
09/12/2003WO2003074504A2 Process and intermediates for preparing phenylthiomethyl-thiazoles or oxazoles
09/12/2003WO2003074498A1 Cyclic compound, process for producing the same, and pest control agent
09/12/2003WO2003074491A1 O-cyclopropyl-carboxanilides and their use as fungicides
09/12/2003WO2003074483A1 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
09/12/2003WO2003074053A1 Use of epothilones in the treatment of brain diseases associated with proliferative processes
09/12/2003WO2003074052A1 Thiazole and oxazole derivatives that modulate ppar activity
09/12/2003WO2003074051A1 Substituted thiazoles and oxazoles that modulate ppar activity
09/12/2003WO2003074050A1 Thiazole and oxazole derivatives which modulate ppar activity
09/12/2003WO2003073987A2 Compounds that modulate the activity of ptp-1b and tc-ptp
09/12/2003WO2002058695A9 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/12/2003WO2001083800A9 Heterologous production of polyketides
09/12/2003CA2478520A1 Thiazole and oxazole derivatives which modulate ppar activity
09/12/2003CA2478164A1 Substituted thiazoles and oxazoles that modulate ppar activity
09/12/2003CA2477715A1 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
09/12/2003CA2477403A1 Use of epothilones in the treatment of brain diseases associated with proliferative processes
09/12/2003CA2477119A1 Compounds that modulate the activity of ptp-1b and tc-ptp
09/12/2003CA2476580A1 Thiazole and oxazole derivatives that modulate ppar activity
09/12/2003CA2472298A1 Coumarines useful as biomarkers
09/11/2003WO2003074500A2 N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
09/11/2003US20030171596 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
09/11/2003US20030171591 Process for producing optically active sulfoxide derivative
09/11/2003US20030171413 Rheumatic diseases; antiarthritic agents; asthma
09/11/2003US20030171411 Amide derivatives as therapeutic agents
09/11/2003US20030171403 Blockade of voltage dependent sodium channels
09/11/2003US20030171400 Rheumatic diseases; osteoporosis; multiple sclerosis; autoimmune disease; joint replacements
09/11/2003US20030171399 Quinolinyl and benzothiazolyl modulators
09/11/2003US20030171377 Therapy for non-insulin dependent diabetes
09/11/2003US20030171369 Quinolylpropylpiperidine derivatives, their preparation, and compositions containing them
09/11/2003US20030171367 Nitrogen-containing tricyclic compounds and drugs containing the same
1 ... 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 ... 628